Profile data is unavailable for this security.
About the company
BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
- Revenue in USD (TTM)9.78m
- Net income in USD-2.66m
- Incorporated2017
- Employees30.00
- LocationBioNexus Gene Lab CorpTower B, Vertical Business Suite, 10-2,KUALA LUMPUR 59200MalaysiaMYS
- Phone+0 160 122126512
- Websitehttps://www.bionexusgenelab.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Templates Inc | 31.76m | -18.40m | 9.41m | 62.00 | -- | 1.31 | -- | 0.2964 | -4.36 | -4.36 | 5.98 | 1.09 | 0.6014 | -- | 19.55 | 512,306.40 | -34.83 | -51.78 | -54.80 | -73.14 | -- | -- | -57.92 | -228.33 | -- | -52.11 | 0.00 | -- | 190.10 | 33.96 | 91.24 | -- | -48.87 | -- |
| Notable Labs Ltd | 310.00k | -11.26m | 9.47m | 16.00 | -- | 0.6265 | -- | 30.55 | -3.08 | -3.08 | 0.0939 | 1.68 | 0.0126 | -- | -- | 19,375.00 | -45.79 | -52.02 | -56.70 | -62.09 | 36.45 | 60.19 | -3,633.55 | -3,636.93 | -- | -- | 0.0221 | -- | -52.89 | -11.93 | 65.13 | -- | -50.69 | -- |
| Viaderma Inc | 17.80m | 2.31m | 9.58m | 75.00 | 0.0005 | 0.00003 | 1.77 | 0.5382 | 16.84 | 16.84 | 129.62 | 255.59 | 0.4126 | 24.69 | 1.21 | 237,331.30 | 5.36 | -- | 6.53 | -- | 28.90 | -- | 12.99 | -- | 2.07 | 5.66 | 0.1718 | -- | -29.15 | -- | -40.70 | -- | -- | -- |
| Weed Inc | 0.00 | -31.55k | 9.61m | 2.00 | -- | 37.66 | 336.87 | -- | -0.0002 | -0.0002 | 0.00 | 0.0021 | 0.00 | -- | -- | 0.00 | -2.49 | -385.93 | -14.84 | -822.37 | -- | -- | -- | -- | -- | -16.98 | 0.3488 | -- | -- | -- | 97.93 | -- | -59.13 | -- |
| Kintara Therapeutics Inc | 0.00 | -9.51m | 9.68m | 2.00 | -- | -- | -- | -- | -4.08 | -4.08 | 0.00 | 0.1071 | 0.00 | -- | -- | 0.00 | -131.55 | -220.94 | -185.60 | -329.97 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 40.24 | -- | 78.93 | -- |
| Medical Marijuana Inc | -100.00bn | -100.00bn | 9.77m | -- | -- | 0.1052 | -- | -- | -- | -- | -- | 0.019 | -- | -- | -- | -- | -- | -22.66 | -- | -23.11 | -- | 70.58 | -- | -145.52 | 1.79 | -- | 0.0479 | -- | 26.30 | 39.07 | 141.59 | -- | -0.016 | -- |
| BioNexus Gene Lab Corp | 9.78m | -2.66m | 10.08m | 30.00 | -- | 1.08 | -- | 1.03 | -0.14 | -0.14 | 0.651 | 0.5289 | 1.01 | 8.55 | 5.80 | -- | -27.53 | -3.83 | -33.16 | -5.02 | 13.56 | 14.55 | -27.25 | -3.04 | 3.98 | -162.45 | 0.00 | -- | -10.60 | 115.07 | -638.56 | -- | 30.40 | -- |
| Galera Therapeutics Inc | 0.00 | -45.75m | 10.13m | 7.00 | -- | -- | -- | -- | -0.9971 | -0.9971 | 0.00 | -2.48 | 0.00 | -- | -- | 0.00 | -115.30 | -83.69 | -142.79 | -97.54 | -- | -- | -- | -- | -- | -6.49 | 9.23 | -- | -- | -- | 5.05 | -- | -29.84 | -- |
| Guardion Health Sciences Inc | 12.06m | -5.12m | 10.14m | 9.00 | -- | 2.97 | -- | 0.841 | -4.00 | -4.00 | 9.49 | 2.66 | 0.9718 | 2.63 | 5.96 | 1,340,280.00 | -41.26 | -77.90 | -47.92 | -86.55 | 43.43 | 42.45 | -42.46 | -176.93 | 6.49 | -4.24 | 0.00 | -- | 10.85 | 67.03 | 101.00 | -- | -58.56 | -- |
| Chromocell Therapeutics Corp | 0.00 | -8.98m | 10.50m | 4.00 | -- | 9.29 | -- | -- | -1.66 | -1.66 | 0.00 | 0.196 | 0.00 | -- | -- | 0.00 | -440.01 | -- | -- | -- | -- | -- | -- | -- | -- | -7.20 | 0.00 | -- | -- | -- | -200.20 | -- | -- | -- |
| Scorpius Holdings Inc | 2.23m | -46.05m | 10.54m | 77.00 | -- | 0.115 | -- | 4.73 | -1.78 | -2.00 | 0.0859 | 1.39 | 0.0234 | -- | 0.6762 | 28,918.57 | -50.05 | -38.42 | -61.25 | -42.06 | 29.10 | -- | -2,136.28 | -703.02 | -- | -- | 0.2305 | -- | 202.12 | 33.24 | -23.85 | -- | 218.50 | -- |
| Endexx Corp | 4.64m | 6.93m | 10.54m | -- | 1.57 | -- | 1.78 | 2.27 | 0.0133 | 0.0133 | 0.0091 | -0.0255 | 0.6773 | 4.37 | 13.54 | -- | 86.51 | -- | -- | -- | 28.73 | -- | 127.74 | -- | 0.0664 | -- | -- | -- | 228.66 | -- | 28.26 | -- | -- | -- |
| BioCardia Inc | 468.00k | -10.34m | 10.70m | 16.00 | -- | -- | -- | 22.87 | -0.4692 | -0.4692 | 0.0209 | -0.0848 | 0.0954 | -- | 4.44 | 29,250.00 | -210.81 | -107.34 | -1,190.90 | -154.17 | -- | -- | -2,208.76 | -1,779.24 | -- | -- | -- | -- | -64.72 | -5.26 | 2.82 | -- | -28.89 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Virtu Americas LLCas of 31 Dec 2023 | 26.15k | 0.15% |
| Geode Capital Management LLCas of 31 Mar 2024 | 23.68k | 0.13% |
| HRT Financial LLCas of 31 Mar 2024 | 21.90k | 0.12% |
| UBS Securities LLCas of 31 Mar 2024 | 8.42k | 0.05% |
| Citadel Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
| Tower Research Capital LLCas of 31 Mar 2024 | 0.00 | 0.00% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
